Bio-Connect

InVivoMAb anti-Zika virus E protein DIII-LR

BE0431
Bio X Cell
ApplicationsFlow Cytometry, Western Blot, ELISA, Neutralisation/Blocking, Other Application
Product group Antibodies
ReactivityVirus
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bio X Cell
  • Product Name
    InVivoMAb anti-Zika virus E protein DIII-LR
  • Delivery Days Customer
    7
  • Applications
    Flow Cytometry, Western Blot, ELISA, Neutralisation/Blocking, Other Application
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    ZV-67
  • Concentration
    4-11 mg/ml
  • Estimated Purity
    >95%
  • Host
    Mouse
  • Isotype
    IgG2c
  • Reactivity
    Virus
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Kikawa C, Cartwright-Acar CH, Stuart JB, et al. The effect of single mutations in Zika virus envelope on escape from broadly neutralizing antibodies. J Virol. 2023,97(11):e0141423. doi: 10.1128/jvi.01414-23
    Read this paper
  • Bollman B, Nunna N, Bahl K, et al. An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection. NPJ Vaccines. 2023,8(1):58. doi: 10.1038/s41541-023-00656-4
    Read this paper
  • Reynoso GV, Gordon DN, Kalia A, et al. Zika virus spreads through infection of lymph node-resident macrophages. Cell Rep. 2023,42(2):112126. doi: 10.1016/j.celrep.2023.112126
    Read this paper
  • Georgiev GI, Malonis RJ, Wirchnianski AS, et al. Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivo. Cell Chem Biol. 2022,29(5):811-823.e7. doi: 10.1016/j.chembiol.2022.02.004
    Read this paper
  • Kim SI, Kim S, Shim JM, et al. Neutralization of Zika virus by E protein domain III-Specific human monoclonal antibody. Biochem Biophys Res Commun. 2021,545:33-39. doi: 10.1016/j.bbrc.2021.01.075
    Read this paper
  • Maciejewski S, Ruckwardt TJ, Morabito KM, et al. Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality. Sci Transl Med. 2020,12(547):pii: eaaw9066. doi: 10.1126/scitranslmed.aaw9066.
    Read this paper
  • Zhao H, Xu L, Bombardi R, et al. Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge. J Exp Med. 2020,217(2). doi: 10.1084/jem.20191792
    Read this paper
  • Gao Y, Tai W, Wang N, et al. Identification of Novel Natural Products as Effective and Broad-Spectrum Anti-Zika Virus Inhibitors. Viruses. 2019,11(11). doi: 10.3390/v11111019
    Read this paper
  • Setoh YX, Amarilla AA, Peng NYG, et al. Determinants of Zika virus host tropism uncovered by deep mutational scanning. Nat Microbiol. 2019,4(5):876-887. doi: 10.1038/s41564-019-0399-4
    Read this paper
  • Zhou W, Woodson M, Sherman MB, et al. Exosomes mediate Zika virus transmission through SMPD3 neutral Sphingomyelinase in cortical neurons. Emerg Microbes Infect. 2019,8(1):307-326. doi: 10.1080/22221751.2019.1578188
    Read this paper